Topotecan Suppliers & Bulk Manufacturers
Available Forms: Oral capsules, Injection
Available Strengths: Capsule: 1 mg, 2.5 mg; Injection:4 mg/4 mL
Reference Brands: Hycamtin® (EU & US)
Category:
Oncology Cancer Care
Topotecan (brand Hycamtin®) is a chemotherapy drug used for ovarian, small cell lung, and cervical cancer. Available in IV injection (4 mg/4 mL) and oral capsules (1 mg, 2.5 mg), Topotecan inhibits topoisomerase I, halting cancer cell replication. Sourced globally by B2B pharma suppliers, it is GMP-compliant and widely available in the US and EU.
Topotecan is available in Oral capsules, Injection
and strengths such as Capsule: 1 mg, 2.5 mg; Injection:4 mg/4 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Topotecan is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Topotecan can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Topotecan, marketed under the brand Hycamtin®, is a vital chemotherapy agent used to treat cancers such as ovarian, small cell lung cancer, and cervical cancer. Available in IV injection and oral capsule forms, with strengths like 4 mg/4 mL (injection) and 1 mg (oral capsules), Topotecan works by inhibiting topoisomerase I, preventing cancer cells from replicating. Sourced by B2B pharmaceutical suppliers, Topotecan ensures GMP-compliant manufacturing and a reliable supply to oncology centers in the US and EU, providing effective treatment for aggressive cancers with competitive pricing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing